IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Cardiovascular and Hematological Agents in Medicinal Chemistry

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

1.50

h-Index

2024-2025

 44

Rank

2024-2025

 15439

SJR

2024-2025

 0.339

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Cardiovascular and Hematological Agents in Medicinal Chemistry
Abbreviation Cardiovasc. Hematol. Agents Med. Chem.
Publication Type Journal
Subject Area, Categories, Scope Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)
h-index 44
Overall Rank/Ranking 15439
SCImago Journal Rank (SJR) 0.339
Impact Score 1.50
Publisher Bentham Science Publishers
Country United Arab Emirates
ISSN 18756182, 18715257
Best Quartile Q3
Coverage History 2006-2024




About Cardiovascular and Hematological Agents in Medicinal Chemistry


Cardiovascular and Hematological Agents in Medicinal Chemistry is a journal covering the technologies/fields/categories related to Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3). It is published by Bentham Science Publishers. The overall rank of Cardiovascular and Hematological Agents in Medicinal Chemistry is 15439. According to SCImago Journal Rank (SJR), this journal is ranked 0.339. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 44. The best quartile for this journal is Q3.

The ISSN of Cardiovascular and Hematological Agents in Medicinal Chemistry journal is 18756182, 18715257. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cardiovascular and Hematological Agents in Medicinal Chemistry is cited by a total of 96 articles during the last 3 years (Preceding 2024).


Cardiovascular and Hematological Agents in Medicinal Chemistry Impact IF 2024-2025


The Impact IF 2024 of Cardiovascular and Hematological Agents in Medicinal Chemistry is 1.50, which is computed in 2025 as per its definition. Cardiovascular and Hematological Agents in Medicinal Chemistry IF is increased by a factor of 0.22 and approximate percentage change is 17.19% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Cardiovascular and Hematological Agents in Medicinal Chemistry Impact IF 2025 Prediction


Impact IF 2024 of Cardiovascular and Hematological Agents in Medicinal Chemistry is 1.50. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Cardiovascular and Hematological Agents in Medicinal Chemistry. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 1.50
2023 1.28
2022 1.37
2021 2.06
2020 1.85
2019 1.31
2018 1.03
2017 0.81
2016 0.70
2015 0.84
2014 1.23

Cardiovascular and Hematological Agents in Medicinal Chemistry h-index


  Table Setting

Cardiovascular and Hematological Agents in Medicinal Chemistry has an h-index of 44. It means 44 articles of this journal have more than 44 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Cardiovascular and Hematological Agents in Medicinal Chemistry ISSN


The ISSN of Cardiovascular and Hematological Agents in Medicinal Chemistry is 18756182, 18715257. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Cardiovascular and Hematological Agents in Medicinal Chemistry Rank and SCImago Journal Rank (SJR)


The overall rank of Cardiovascular and Hematological Agents in Medicinal Chemistry is 15439. According to SCImago Journal Rank (SJR), this journal is ranked 0.339. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Cardiovascular and Hematological Agents in Medicinal Chemistry by Year


Year SJR
2025/2026 Coming Soon
2024 0.339
2023 0.356
2022 0.268
2021 0.409
2020 0.415
2019 0.246
2018 0.307
2017 0.336
2016 0.359
2015 0.515
2014 0.532

Ranking of Cardiovascular and Hematological Agents in Medicinal Chemistry by Year


Year Ranking
2025/2026 Coming Soon
2024 15439
2023 14135
2022 16207
2021 11865
2020 11754
2019 16312
2018 13527
2017 12342
2016 11930
2015 8973
2014 8526

Cardiovascular and Hematological Agents in Medicinal Chemistry Publisher


Table Setting

Cardiovascular and Hematological Agents in Medicinal Chemistry is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Cardiovascular and Hematological Agents in Medicinal Chemistry is Cardiovasc. Hematol. Agents Med. Chem.. This abbreviation ('Cardiovasc. Hematol. Agents Med. Chem.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Cardiovascular and Hematological Agents in Medicinal Chemistry


If your research field is/are related to Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

Cardiovascular and Hematological Agents in Medicinal Chemistry latest impact IF is 1.50. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 2.06 (2021) and 0.70 (2016), respectively, in the last 11 years. Moreover, its average IS is 1.27 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry has an SJR (SCImago Journal Rank) of 0.339, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.532 in 2014 and the lowest being 0.246 in 2019. Furthermore, the average SJR of the Cardiovascular and Hematological Agents in Medicinal Chemistry over the previous 11-year period stands at 1.27.


What's the latest h-index of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The latest h-index of the Cardiovascular and Hematological Agents in Medicinal Chemistry is 44.


Who's the publisher of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.


What's the current ranking of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry is currently ranked 15439 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 8526 in 2014 and its lowest position of 16312 in 2019.


What's the abbreviation or short name for the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The standard ISO4 abbreviation for the Cardiovascular and Hematological Agents in Medicinal Chemistry is Cardiovasc. Hematol. Agents Med. Chem..


Is the "Cardiovascular and Hematological Agents in Medicinal Chemistry" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Cardiovascular and Hematological Agents in Medicinal Chemistry is classified as a journal that the Bentham Science Publishers publishes.


What's the scope or major areas of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry encompasses the following areas:

  • Cardiology and Cardiovascular Medicine
  • Hematology
  • Medicine (miscellaneous)
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry is assigned the following International Standard Serial Numbers (ISSN): 18756182, 18715257.


What's the best quartile of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The best quartile for the Cardiovascular and Hematological Agents in Medicinal Chemistry is Q3 (2024).


What's the coverage history of the Cardiovascular and Hematological Agents in Medicinal Chemistry?

The Cardiovascular and Hematological Agents in Medicinal Chemistry coverage history can be summarized as follows: 2006-2024.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Qualitative Research journal 1300 SAGE Publications Ltd 101 6.77
Clinical Medicine and Research journal 14921 Marshfield Clinic 64 1.25
Criminal Justice Review journal 10284 SAGE Publications Inc. 46 1.91
Archives of Phytopathology and Plant Protection journal 16692 Taylor and Francis Ltd. 35 1.42
Tekstilec trade journal 17340 University of Ljubljana Press 16 1.29
Biological Procedures Online journal 5232 BioMed Central Ltd 51 4.00
European Journal of Wildlife Research journal 10254 Springer Verlag 62 1.99
Transboundary and Emerging Diseases journal 5531 John Wiley and Sons Ltd 92 3.26
Metascience journal 24313 Springer Nature 3 0.00
PLoS ONE journal 6756 Public Library of Science 467 2.82

Check complete list




Year wise Impact Score (IS) of Cardiovascular and Hematological Agents in Medicinal Chemistry

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 1.50
2023 1.28
2022 1.37
2021 2.06
2020 1.85
2019 1.31
2018 1.03
2017 0.81
2016 0.70
2015 0.84
2014 1.23



Top Journals/Conferences in Cardiology and Cardiovascular Medicine

Nature Reviews Cardiology
Nature Research | United Kingdom

Journal of the American College of Cardiology
Elsevier Inc. | United States

Circulation
Lippincott Williams and Wilkins | United States

JAMA Cardiology
American Medical Association | United States

European Journal of Heart Failure
John Wiley and Sons Ltd | United Kingdom

JACC: Cardiovascular Imaging
Elsevier Inc. | United States

JACC: Heart Failure
Elsevier Inc. | United States

European Heart Journal
Oxford University Press | United Kingdom

Circulation Research
Lippincott Williams and Wilkins | United States

Nature Cardiovascular Research
Springer | Germany

See All

Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
John Wiley and Sons Inc | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Blood
Elsevier B.V. | United States

Blood Cancer Journal
Springer Nature | United Kingdom

Lancet Haematology,The
Elsevier Ltd | United Kingdom

Blood cancer discovery
NLM (Medline) | United States

Leukemia
Springer Nature | United Kingdom

Experimental Hematology and Oncology
BioMed Central Ltd | United Kingdom

American Journal of Hematology
John Wiley and Sons Inc | United States

See All

Top Journals/Conferences in Medicine (miscellaneous)

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Research | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Nature Medicine
Nature Research | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Annual Review of Pathology: Mechanisms of Disease
Annual Reviews Inc. | United States

Physiological Reviews
American Physiological Society | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All